How should N‑acetylcysteine (Parvolex) 2 g in 10 mL be prepared for nebulisation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Preparing Parvolex (N-acetylcysteine) 2g/10ml for Nebulisation

Add the 10ml Parvolex ampoule directly to the nebuliser chamber and dilute with 0.9% sodium chloride to achieve a total volume of 2.0-4.5ml, then nebulise using a gas flow rate of 6-8 L/min for approximately 10-15 minutes.

Preparation Steps

Based on British Thoracic Society guidelines, the optimal preparation involves:

  • Volume considerations: The nebuliser chamber should contain 2.0-4.5ml total volume 1. Since your Parvolex ampoule is already 10ml, you would use this volume directly if your nebuliser accommodates it, or reduce the volume proportionally while maintaining the 2g dose.

  • Dilution requirements: If using a nebuliser with residual volume >1.0ml, make up to a minimum of 4.0ml with 0.9% sodium chloride (never water, as it may cause bronchoconstriction) 1.

  • Gas flow rate: Use 6-8 L/min to generate particles of 2-5 µm diameter for optimal small airway deposition 1.

Administration Parameters

  • Driving gas: Use compressed air or an electrical compressor. Oxygen should only be used in acute severe asthma; avoid oxygen in COPD patients due to CO2 retention risk 1.

  • Duration: Nebulise until approximately one minute after "spluttering" occurs, typically 10-15 minutes 1. N-acetylcysteine and other viscous solutions may require longer nebulisation times than standard bronchodilators 1.

  • Interface: Use a mouthpiece rather than a mask to prevent facial deposition and allow for filter attachment if needed 1.

Important Caveats

Stability: If preparing the solution in advance, inhalational N-acetylcysteine compounded in D5W remains stable for up to 60 hours and is free from bacterial contamination 2. However, drugs should ideally be placed in the nebuliser immediately before use 1.

Bronchospasm risk: While N-acetylcysteine can theoretically cause bronchospasm, studies show that when nebulised with a bronchodilator like isoproterenol, no bronchospasm occurred 3. Consider pre-treatment with a bronchodilator in reactive airway patients.

Post-treatment care: Instruct the patient to rinse their mouth after nebulisation to prevent oral complications 1.

Equipment maintenance: Clean the nebuliser chamber and mouthpiece after each use with warm water and detergent, then dry thoroughly to prevent bacterial growth 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.